Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor (Q34484174)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q49880375)
(Q42947998)
(Q46460242)
(Q6384357)
(Q66809426)
(Q84698958)
(Q114291532)
(Q92215315)
(Q94947567)
(Q117251008)
(Q64683306)
(Q92132969)
(Q114523104)
(Q89012472)
(Q117251009)
(Q85636421)
(Q114439514)
(Q114522987)
(Q57562237)
(P304) 3697-3704
(P407) (Q1860)
(P433) 33
(P478) 32
(P577) Monday, October 6, 2014
(P1433) (Q400292)
(P1476) "Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor" (language: en)
(P2093) Douglas B Johnson
Kevin B Kim
Donald P Lawrence
Geoffrey T Gibney
Karl Lewis
Peng Sun
Elizabeth Cunningham
Rene Gonzalez
(P2860) (Q39030603)
(Q37606223)
(Q37626175)
(Q37626102)
(Q27852692)
(Q37641646)
(Q27777363)
(Q36793719)
(Q39873892)
(Q24632064)
(Q34032640)
(Q29617359)
(Q29614756)
(Q29620663)
(Q28730438)
(Q36489360)
(Q24594790)
(Q37048053)
(Q29620033)
(Q24631953)
(Q27851628)
(Q29614757)
(Q24629474)
(Q29615032)
(Q33906093)
(Q28131668)
(Q39971699)
(Q29614965)
(Q27860760)
(Q44382713)
other details
description scientific article

External Links